Annual Accounts Payable
$993.10 K
+$502.40 K+102.38%
31 December 2023
Summary:
ZIVO Bioscience annual accounts payable is currently $993.10 thousand, with the most recent change of +$502.40 thousand (+102.38%) on 31 December 2023. During the last 3 years, it has fallen by -$566.50 thousand (-36.32%). ZIVO annual accounts payable is now -36.32% below its all-time high of $1.56 million, reached on 31 December 2020.ZIVO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$923.90 K
-$249.00 K-21.23%
30 September 2024
Summary:
ZIVO Bioscience quarterly accounts payable is currently $923.90 thousand, with the most recent change of -$249.00 thousand (-21.23%) on 30 September 2024. Over the past year, it has increased by +$280.10 thousand (+43.51%). ZIVO quarterly accounts payable is now -51.40% below its all-time high of $1.90 million, reached on 30 September 2020.ZIVO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +102.4% | +43.5% |
| 3 y3 years | -36.3% | +26.8% |
| 5 y5 years | +135.1% | -4.0% |
ZIVO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.3% | +102.4% | -27.4% | +126.6% |
| 5 y | 5 years | -36.3% | +135.1% | -51.4% | +126.6% |
| alltime | all time | -36.3% | -51.4% |
ZIVO Bioscience Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $923.90 K(-21.2%) |
| June 2024 | - | $1.17 M(+27.9%) |
| Mar 2024 | - | $917.00 K(-21.3%) |
| Dec 2023 | $993.10 K(+102.4%) | $1.17 M(+81.1%) |
| Sept 2023 | - | $643.80 K(-49.4%) |
| June 2023 | - | $1.27 M(+90.0%) |
| Mar 2023 | - | $670.30 K(+36.6%) |
| Dec 2022 | $490.70 K(-25.0%) | $490.70 K(-19.2%) |
| Sept 2022 | - | $607.00 K(+48.8%) |
| June 2022 | - | $407.80 K(-21.6%) |
| Mar 2022 | - | $520.40 K(-20.5%) |
| Dec 2021 | $654.30 K(-58.0%) | $654.30 K(-10.2%) |
| Sept 2021 | - | $728.80 K(-20.6%) |
| June 2021 | - | $918.30 K(-47.1%) |
| Mar 2021 | - | $1.74 M(+11.3%) |
| Dec 2020 | $1.56 M(+13.6%) | $1.56 M(-18.0%) |
| Sept 2020 | - | $1.90 M(+27.9%) |
| June 2020 | - | $1.49 M(-18.5%) |
| Mar 2020 | - | $1.82 M(+32.9%) |
| Dec 2019 | $1.37 M(+224.9%) | $1.37 M(+42.6%) |
| Sept 2019 | - | $962.20 K(-17.5%) |
| June 2019 | - | $1.17 M(+45.2%) |
| Mar 2019 | - | $802.80 K(-6.1%) |
| Dec 2018 | $422.40 K(-22.0%) | $854.90 K(+117.5%) |
| Sept 2018 | - | $393.10 K(-12.7%) |
| June 2018 | - | $450.40 K(-60.2%) |
| Mar 2018 | - | $1.13 M(+11.2%) |
| Dec 2017 | $541.70 K(-18.7%) | $1.02 M(+60.2%) |
| Sept 2017 | - | $635.00 K(-16.5%) |
| June 2017 | - | $760.10 K(-1.2%) |
| Mar 2017 | - | $769.10 K(+15.4%) |
| Dec 2016 | $666.40 K(-40.2%) | $666.40 K(-19.1%) |
| Sept 2016 | - | $823.70 K(-25.9%) |
| June 2016 | - | $1.11 M(-11.1%) |
| Mar 2016 | - | $1.25 M(+12.2%) |
| Dec 2015 | $1.11 M(-9.1%) | $1.11 M(-8.6%) |
| Sept 2015 | - | $1.22 M(+2.7%) |
| June 2015 | - | $1.19 M(-14.1%) |
| Mar 2015 | - | $1.38 M(+12.8%) |
| Dec 2014 | $1.23 M(+153.6%) | $1.23 M(+153.7%) |
| Sept 2014 | - | $483.00 K(-29.2%) |
| June 2014 | - | $682.40 K(+13.7%) |
| Mar 2014 | - | $600.40 K(+24.3%) |
| Dec 2013 | $483.20 K(-48.5%) | $483.20 K(-48.5%) |
| Sept 2013 | - | $938.80 K(+17.0%) |
| June 2013 | - | $802.50 K(-12.3%) |
| Mar 2013 | - | $915.00 K(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $938.60 K(+42.1%) | $938.60 K(+7.3%) |
| Sept 2012 | - | $874.70 K(+21.0%) |
| June 2012 | - | $723.00 K(+10.3%) |
| Mar 2012 | - | $655.50 K(-0.8%) |
| Dec 2011 | $660.60 K(+45.0%) | $660.60 K(+8.4%) |
| Sept 2011 | - | $609.40 K(-1.6%) |
| June 2011 | - | $619.20 K(+20.2%) |
| Mar 2011 | - | $515.00 K(+13.0%) |
| Dec 2010 | $455.60 K(-15.9%) | $455.60 K(-5.7%) |
| Sept 2010 | - | $482.90 K(-1.8%) |
| June 2010 | - | $491.90 K(-3.0%) |
| Mar 2010 | - | $507.30 K(-6.4%) |
| Dec 2009 | $541.90 K(+6.4%) | $541.90 K(+13.0%) |
| Sept 2009 | - | $479.70 K(-9.1%) |
| June 2009 | - | $528.00 K(+2.9%) |
| Mar 2009 | - | $513.10 K(+0.7%) |
| Dec 2008 | $509.30 K(-4.5%) | $509.30 K(-11.5%) |
| Sept 2008 | - | $575.70 K(+24.5%) |
| June 2008 | - | $462.50 K(+3.4%) |
| Mar 2008 | - | $447.50 K(-16.1%) |
| Dec 2007 | $533.30 K(+6.6%) | $533.30 K(+13.9%) |
| Sept 2007 | - | $468.20 K(+10.2%) |
| June 2007 | - | $424.80 K(+7.7%) |
| Mar 2007 | - | $394.50 K(-21.2%) |
| Dec 2006 | $500.50 K(+212.6%) | $500.50 K(+105.8%) |
| Sept 2006 | - | $243.20 K(+16.3%) |
| June 2006 | - | $209.20 K(+144.7%) |
| Mar 2006 | - | $85.50 K(-46.6%) |
| Dec 2005 | $160.10 K(-60.7%) | $160.10 K(+171.8%) |
| Sept 2005 | - | $58.90 K(+69.7%) |
| June 2005 | - | $34.70 K(-88.7%) |
| Mar 2005 | - | $307.60 K(-24.4%) |
| Dec 2004 | $406.90 K(+1401.5%) | $406.90 K(+90.3%) |
| Sept 2004 | - | $213.80 K(+142.1%) |
| June 2004 | - | $88.30 K(+99.8%) |
| Mar 2004 | - | $44.20 K(+63.1%) |
| Dec 2003 | $27.10 K(>+9900.0%) | $27.10 K(>+9900.0%) |
| Sept 2002 | - | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | $1600.00 | $1600.00(>+9900.0%) |
| Sept 2000 | - | $0.00(0.0%) |
| June 2000 | - | $0.00 |
FAQ
- What is ZIVO Bioscience annual accounts payable?
- What is the all time high annual accounts payable for ZIVO Bioscience?
- What is ZIVO Bioscience annual accounts payable year-on-year change?
- What is ZIVO Bioscience quarterly accounts payable?
- What is the all time high quarterly accounts payable for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly accounts payable year-on-year change?
What is ZIVO Bioscience annual accounts payable?
The current annual accounts payable of ZIVO is $993.10 K
What is the all time high annual accounts payable for ZIVO Bioscience?
ZIVO Bioscience all-time high annual accounts payable is $1.56 M
What is ZIVO Bioscience annual accounts payable year-on-year change?
Over the past year, ZIVO annual accounts payable has changed by +$502.40 K (+102.38%)
What is ZIVO Bioscience quarterly accounts payable?
The current quarterly accounts payable of ZIVO is $923.90 K
What is the all time high quarterly accounts payable for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly accounts payable is $1.90 M
What is ZIVO Bioscience quarterly accounts payable year-on-year change?
Over the past year, ZIVO quarterly accounts payable has changed by +$280.10 K (+43.51%)